SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression

Silencing of SOCS1 protein with shRNAi lentivirus (shR-SOCS1) led to partial reversion of the tumorigenic phenotype of B16F10-Nex2 melanoma cells. SOCS1 silencing inhibited cell migration and invasion as well as in vitro growth by cell cycle arrest at S phase with increased cell size and nuclei. Dow...

Descripción completa

Detalles Bibliográficos
Autores principales: Berzaghi, R., Maia, V. S. C., Pereira, F. V., Melo, F. M., Guedes, M. S., Origassa, C. S. T., Scutti, J. B., Matsuo, A. L., Câmara, N. O. S., Rodrigues, E. G., Travassos, L. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227698/
https://www.ncbi.nlm.nih.gov/pubmed/28079159
http://dx.doi.org/10.1038/srep40585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227698/
https://www.ncbi.nlm.nih.gov/pubmed/28079159
http://dx.doi.org/10.1038/srep40585

Ejemplares similares